Financial reports
10-Q
2016 Q2
Quarterly report
5 Aug 16
10-Q
2016 Q1
Quarterly report
5 May 16
10-K
2015 FY
Annual report
3 Mar 16
10-Q
2015 Q3
Quarterly report
5 Nov 15
10-Q
2015 Q2
Quarterly report
6 Aug 15
10-K/A
2014 FY
Annual report (amended)
10 Jul 15
10-Q
2015 Q1
Quarterly report
7 May 15
10-K
2014 FY
Annual report
10 Mar 15
10-Q
2014 Q3
Quarterly report
10 Nov 14
Current reports
8-K
Entry into a Material Definitive Agreement
7 Sep 16
8-K
Entry into a Material Definitive Agreement
27 Jul 16
8-K
Departure of Directors or Certain Officers
17 Jun 16
8-K
Sequenom, Inc. Reports First Quarter 2016 Results
5 May 16
8-K/A
Sequenom Completes Consolidation of North Carolina Operations
22 Apr 16
8-K
Sequenom, Inc. Reports 2015 Financial Results
3 Mar 16
8-K
Amendments to Articles of Incorporation or Bylaws
28 Jan 16
8-K
Cost Associated with Exit or Disposal Activities
13 Jan 16
8-K
PROVIDES UPDATE ON MaterniT® GENOME
11 Jan 16
8-K
Sequenom Announces Appointment of Dirk Van Den Boom As President and Chief Executive Officer
11 Dec 15
Registration and prospectus
15-12G
Securities registration termination
23 Sep 16
POS AM
Prospectus update (post-effective amendment)
15 Sep 16
POS AM
Prospectus update (post-effective amendment)
15 Sep 16
POS AM
Prospectus update (post-effective amendment)
15 Sep 16
POS AM
Prospectus update (post-effective amendment)
15 Sep 16
S-8 POS
Registration of securities for employees (post-effective amendment)
15 Sep 16
S-8 POS
Registration of securities for employees (post-effective amendment)
15 Sep 16
S-8 POS
Registration of securities for employees (post-effective amendment)
15 Sep 16
S-8 POS
Registration of securities for employees (post-effective amendment)
15 Sep 16
S-8 POS
Registration of securities for employees (post-effective amendment)
15 Sep 16
Proxies
DEF 14A
Definitive proxy
27 Apr 16
DEFA14A
Additional proxy soliciting materials
27 Apr 16
PRE 14A
Preliminary proxy
15 Apr 16
DEF 14A
Definitive proxy
28 Apr 15
DEFA14A
Additional proxy soliciting materials
28 Apr 15
PRE 14A
Preliminary proxy
17 Apr 15
DEF 14A
Definitive proxy
25 Apr 14
DEFA14A
Additional proxy soliciting materials
25 Apr 14
DEF 14A
Definitive proxy
26 Apr 13
DEFA14A
Additional proxy soliciting materials
26 Apr 13
Other
EFFECT
Notice of effectiveness
22 Sep 16
EFFECT
Notice of effectiveness
22 Sep 16
EFFECT
Notice of effectiveness
22 Sep 16
EFFECT
Notice of effectiveness
22 Sep 16
CT ORDER
Confidential treatment order
21 Sep 16
CT ORDER
Confidential treatment order
14 Jun 16
CT ORDER
Confidential treatment order
31 May 16
EFFECT
Notice of effectiveness
2 Oct 15
CORRESP
Correspondence with SEC
1 Oct 15
UPLOAD
Letter from SEC
30 Sep 15
Ownership
SC 13G/A
Sequenom Inc
12 Jan 17
3
Initial statement of insider ownership
7 Sep 16
3
der Vaart Sandra D van
7 Sep 16
3
Benjamin R Miller
7 Sep 16
3
GLENN A EISENBERG
7 Sep 16
3
F SAMUEL EBERTS III
7 Sep 16
3
WILLIAM HAAS
7 Sep 16
4
GOLDMAN MYLA LAI
7 Sep 16
4
DEN BOOM DIRK VAN
7 Sep 16
4
Change in insider ownership
7 Sep 16